Literature DB >> 2015138

Indications for and results of operative treatment of spondylitis and spondylodiscitis.

A Krödel1, H Stürz, C H Siebert.   

Abstract

We present a retrospective follow-up study of 24 patients with spondylitis or spondylodiscitis whose treatment included surgical intervention. Tuberculous spondylitis was diagnosed in 14 patients and 10 suffered from non-specific spondylitis. The average age of the patients was 50.2 years and average follow-up was 3 years. All patients were asymptomatic at the time of examination and showed radiographic evidence of solid fusion. We recommend radical debridement and spinal fusion through a ventral approach in patients with destruction of the ventral vertebral body, progressive neurological impairment, septicaemia and antibiotic-resistant, symptomatic infections of the spine. In the elderly patient, even in reduced states of health, early surgical intervention can be particularly valuable. Although surgical intervention should be reserved for specific indications, we were able to document favourable results in all 24 patients treated with debridement and spinal fusion.

Entities:  

Mesh:

Year:  1991        PMID: 2015138     DOI: 10.1007/bf00393878

Source DB:  PubMed          Journal:  Arch Orthop Trauma Surg        ISSN: 0936-8051            Impact factor:   3.067


  16 in total

1.  Osteomyelitis of the spine.

Authors:  B H ROBINSON; M H LESSOF
Journal:  Guys Hosp Rep       Date:  1961

2.  Pyogenic non-tuberculous spinal infection: an analysis of thirty cases.

Authors:  J M Digby; J B Kersley
Journal:  J Bone Joint Surg Br       Date:  1979-02

3.  Pyogenic infections occurring primarily in intervertebral discs.

Authors:  H B Kemp; J W Jackson; J D Jeremiah; A J Hall
Journal:  J Bone Joint Surg Br       Date:  1973-11

4.  Prediction of the angle of gibbus deformity in tuberculosis of the spine.

Authors:  S Rajasekaran; T K Shanmugasundaram
Journal:  J Bone Joint Surg Am       Date:  1987-04       Impact factor: 5.284

5.  [Treatment of tuberculous spondylitis with special reference to indications for operative debridement].

Authors:  P Kessler; H Leibe
Journal:  Beitr Orthop Traumatol       Date:  1982-04

6.  [Inflammatory diseases of the spinal column].

Authors:  A Göb
Journal:  Chirurg       Date:  1982-05       Impact factor: 0.955

7.  Anterior fusion of the spine for infective lesions in adults.

Authors:  H B Kemp; J W Jackson; J D Jeremiah; J Cook
Journal:  J Bone Joint Surg Br       Date:  1973-11

8.  [Nonspecific bacterial spondylitis--an analysis of 32 cases].

Authors:  P Dufek; G Freiherr von Salis-Soglio; Z Bozdech
Journal:  Z Orthop Ihre Grenzgeb       Date:  1987 May-Jun

9.  Five-year assessments of controlled trials of ambulatory treatment, debridement and anterior spinal fusion in the management of tuberculosis of the spine. Studies in Bulawayo (Rhodesia) and in Hong Kong. Sixth report of the Medical Research Council Working Party on Tuberculosis of the Spine.

Authors: 
Journal:  J Bone Joint Surg Br       Date:  1978-05

10.  Treatment of hematogenous pyogenic vertebral osteomyelitis with anterior debridement and primary bone grafting.

Authors:  S E Emery; D P Chan; H R Woodward
Journal:  Spine (Phila Pa 1976)       Date:  1989-03       Impact factor: 3.468

View more
  12 in total

1.  Extended indications of percutaneous endoscopic lavage and drainage for the treatment of lumbar infectious spondylitis.

Authors:  Shih-Chieh Yang; Wen-Jer Chen; Hung-Shu Chen; Yu-Hsien Kao; Shang-Won Yu; Yuan-Kun Tu
Journal:  Eur Spine J       Date:  2014-01-22       Impact factor: 3.134

Review 2.  Cervical spondylodiscitis: change in clinical picture and operative management during the last two decades. A series of 50 patients and review of literature.

Authors:  M Shousha; C Heyde; H Boehm
Journal:  Eur Spine J       Date:  2014-11-29       Impact factor: 3.134

3.  Percutaneous endoscopic discectomy and drainage for infectious spondylitis.

Authors:  Shih-Chieh Yang; Tsai-Sheng Fu; Lih-Huei Chen; Chi-Chien Niu; Po-Liang Lai; Wen-Jer Chen
Journal:  Int Orthop       Date:  2006-09-05       Impact factor: 3.075

4.  Surgical treatment of spondylodiscitis in the cervical spine: a minimum 2-year follow-up.

Authors:  Christoph E Heyde; Heinrich Boehm; Hesham El Saghir; Sven K Tschöke; Ralph Kayser
Journal:  Eur Spine J       Date:  2006-07-26       Impact factor: 3.134

5.  Identifying pathogens of spondylodiscitis: percutaneous endoscopy or CT-guided biopsy.

Authors:  Shih-Chieh Yang; Tsai-Sheng Fu; Lih-Huei Chen; Wen-Jer Chen; Yuan-Kun Tu
Journal:  Clin Orthop Relat Res       Date:  2008-08-13       Impact factor: 4.176

6.  [Spinal epidural abscess-an interdisciplinary emergency.].

Authors:  C Schaller; M Klein; W Hassler
Journal:  Schmerz       Date:  1995-10       Impact factor: 1.107

7.  Medium-term outcome of posterior surgery in the treatment of non-tuberculous bacterial spinal infection.

Authors:  Ahmed Aljawadi; Gagan Sethi; Eze Imo; Frances Arnall; Muhammad Naghman Choudhry; Kuriakose Joshi George; Anant Tambe; Rajat Verma; Mohammed Naveed Yasin; Saeed Mohammed; Irfan Siddique
Journal:  J Orthop       Date:  2019-06-19

8.  Diagnostic Value of Biopsy Techniques in Lumbar Spondylodiscitis: Percutaneous Needle Biopsy and Open Biopsy.

Authors:  Kyoung Hyup Nam; Geun Sung Song; In Ho Han; Byung Kwan Choi; Seung Heon Cha
Journal:  Korean J Spine       Date:  2011-12-31

9.  Presentation and Outcomes After Medical and Surgical Treatment Versus Medical Treatment Alone of Spontaneous Infectious Spondylodiscitis: A Systematic Literature Review and Meta-Analysis.

Authors:  Davis G Taylor; Avery L Buchholz; Durga R Sure; Thomas J Buell; James H Nguyen; Ching-Jen Chen; Joshua M Diamond; Perry A Washburn; James Harrop; Christopher I Shaffrey; Justin S Smith
Journal:  Global Spine J       Date:  2018-12-13

10.  Minimally invasive endoscopic treatment for lumbar infectious spondylitis: a retrospective study in a tertiary referral center.

Authors:  Shih-Chieh Yang; Tsai-Sheng Fu; Hung-Shu Chen; Yu-Hsien Kao; Shang-Won Yu; Yuan-Kun Tu
Journal:  BMC Musculoskelet Disord       Date:  2014-03-27       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.